DERL3 and colorectal adenocarcinoma: We confirmed the existence of DERL3 CpG island methylation in a second set of primary colorectal adenocarcinomas (n=128) using the DNA methylation microarray platform16, in which it was found in 28% (36 of 128) of patients (Supplementary Table 3).